Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Q3 2024 vs. Q2 2024
How the institutions holding Revolution Medicines, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 223 | 3 | 255 | +35 |
| Shares | 168.4M | 13.6M | 170.7M | +15.9M (+10.3%) |
| Value | $6.54B | $529.3M | $7.74B | +$1.73B (+28.8%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (56)
Institutions that held Revolution Medicines, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (21)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 1,015,776 | $39.4M |
| First Turn Management, LLC | 329,519 | $12.8M |
| Mubadala Investment Co PJSC | 278,000 | $10.8M |
| Point72 Asset Management, L.P. | 227,922 | $8.85M |
| Twinbeech Capital LP | 220,289 | $8.55M |
| Readystate Asset Management LP | 163,241 | $6.34M |
| Engineers Gate Manager LP | 46,159 | $1.79M |
| Gsa Capital Partners LLP | 31,467 | $1.22M |
| XTX Topco Ltd | 23,717 | $920.5K |
| Eisler Capital (US) LLC | 21,395 | $830.3K |
| Simplex Trading, LLC | 17,344 | $673.0K |
| Alpine Global Management, LLC | 16,823 | $652.9K |
| Corvex Management LP | 11,698 | $454.0K |
| HighTower Advisors, LLC | 10,097 | $393.0K |
| Aigen Investment Management, LP | 8,660 | $336.1K |
| Parkwood LLC | 5,845 | $227.0K |
| Pacer Advisors, Inc. | 1,056 | $41.0K |
| Elequin Capital LP | 234 | $9.08K |
| Weiss Asset Management LP | 226 | $8.77K |
| Innealta Capital, LLC | 38 | $1.48K |
| Avion Wealth | 13 | $0 |
Not filed for Q3 2024 yet (3)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 13,408,713 | $520.4M |
| Susquehanna Fundamental Investments, LLC | 228,513 | $8.87M |
| Benjamin F. Edwards & Company, Inc. | 56 | $2.00K |